ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

Director’s Advisory Committee to Make Advice “Kosher”

March 7, 1997